Definium Therapeutics (DFTX) Goodwill (2020 - 2026)

Definium Therapeutics (DFTX) has 7 years of Goodwill data on file, last reported at $19.9 million in Q1 2026.

• Quarterly Goodwill changed 0.0% year-over-year to $19.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $19.9 million, changed 0.0% from the prior year.
• Goodwill held at $19.9 million in Q1 2026 per DFTX's latest filing, from $19.9 million in the prior quarter.
• Across five years, Goodwill topped out at $19.9 million in Q1 2022 and bottomed at $19.9 million in Q1 2022.
• The 5-year median for Goodwill is $19.9 million (2022), against an average of $19.9 million.
• Peak annual rise in Goodwill reached 99.34% in 2022, while the deepest fall reached 0.0% in 2022.
• Tracing DFTX's Goodwill over 5 years: stood at $19.9 million in 2022, then changed by 0.0% to $19.9 million in 2023, then changed by 0.0% to $19.9 million in 2024, then changed by 0.0% to $19.9 million in 2025, then changed by 0.0% to $19.9 million in 2026.
• Per Business Quant, the three latest DFTX Goodwill figures stand at $19.9 million (Q1 2026), $19.9 million (Q4 2025), and $19.9 million (Q3 2025).

Peer Comparison